• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Mercator MedSystems launches BTK micro-infusion trial

Mercator MedSystems launches BTK micro-infusion trial

July 27, 2016 By Fink Densford

Mercator MedSystemsMercator MedSystems said today it enrolled the 1st patient in the Limbo-ATx trial of the company’s Bullfrog micro-infusion device.

The trial is slated to enroll 120 patients and aims to explore the benefit of localized drug delivery using the company’s device in maintaining vascular health when used alongside atherectomy procedures, the company said.

“This is a very important step for Mercator. There is an unmet need in delivering a reliable drug therapy to keep arteries open below the knee. Our results from Micro-Infusion in above-knee arteries from our Dance-Pilot study and our most recent experience from our larger, 285-patient Dance trial provide us with confidence that the Bullfrog Micro-Infusion Device can efficiently deliver the drug directly where it is needed and that doing so could impact decision making in the daily treatment of critical limb ischemia,” CEO Trent Reutiman said in prepared remarks.

In the trial, the Bullfrog micro-infusion device will be used for the local delivery of anti-inflammatory steroids during artherectomy procedures to help reduce injury and inflammation, stop scar tissue buildup and maintain blood flow.

“We are very excited to be one of the centers initiating enrollment of the Limbo-ATX Study. There remains a real need for enhancements in therapy for treating patients with critical limb ischemia, and we hope to show that this therapy can improve patient outcomes and prevent amputation,” co-principal investigator Dr. George Adams of the University of North Carolina REX Hospital said in a prepared statement.

In January, Mercator launched its Limbo-PTA clinical trial, which aims to examine the use of the company’s Bullfrog micro-infusion device as it delivers anti-inflammatory steroids alongside angioplasty to treat patients with below the knee critical limb ischemia.

The Emeryville, Calif.-based company said that the purpose of adding an anti-inflammatory drug, delivered by its Bullfrog device, is to eliminate biological signals that cause scar tissue build up and can lead to restenosis. Mercator said this commonly occurs, and leads to re-obstruction in below-the-knee balloon angioplasty procedures.

The German Limbo-PTA trial is ongoing, and is slated to enroll 120 patients, the company said.

Filed Under: Clinical Trials, Drug Pumps, Vascular Tagged With: Mercator MedSystems

More recent news

  • Imperative Care has positive stroke treatment study results
  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • Intuitive demonstrates remote telesurgery capabilities with da Vinci 5
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • CVRx announces Medicare win for Barostim therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy